AJP - Renal Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 275: F204-F215, 1998;
0363-6127/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berg, J. R.
Right arrow Articles by Lewis, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, J. R.
Right arrow Articles by Lewis, S. A.
Vol. 275, Issue 2, F204-F215, August 1998

Modulation of polymyxin B effects on mammalian urinary bladder

Jamie R. Berg, Christian M. Spilker, and Simon A. Lewis

Department of Physiology and Biophysics, University of Texas Medical Branch, Galveston, Texas 77555

    ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

This report demonstrates that Ca2+, Mg2+, and protons alter the ability of polymyxin B (PX, a cationic antibiotic used clinically as a bactericidal agent) to increase the apical membrane conductance of the rabbit urinary bladder. Using electrophysiological methods, we determine that these alterations occur by two mechanisms. First, they blocked the PX-induced conductance in a rapid and reversible manner; second, they competed with PX for a membrane binding site. In addition, Ca2+ (but not Mg2+ or protons) altered the rate at which the induced conductance could be reversed. When solution pH was greater than 8.8, PX was not able to induce a conductance. This ability of high pH to inhibit the action of PX was due to a decrease in the number of positive charges on PX. Further studies demonstrated that for maximal activity, PX required its fatty acid tail. These data were used to develop a model describing the mechanism by which PX can induce a conductance in the apical membrane of the rabbit urinary bladder.

cationic antibiotic; nonapeptide; tight epithelium; divalent cations; protons; voltage-sensitive conductance

    INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

POLYMYXIN B (PX) is an amphipathic decapeptide that contains five positive charges, has a fatty acid tail, and has a molecular mass of ~1,400. It is used in topical ointments and sometimes as a bactericidal agent in irrigating solutions during long-term catheterization of the urinary bladder and is most active against Gram-negative bacteria. One of the reasons for the limited use of systemic PX is its nephrotoxicity. The mechanism of the bactericidal action of PX on Gram-negative bacteria is to increase the permeability of the bacteria's cytoplasmic membrane to ions and other cellular constituents. Of interest is that the bactericidal potency of PX to Gram-negative bacteria requires the fatty acid tail and is sensitive to the concentration of divalent cations in the bathing medium (23). It has been proposed that the effect of divalent cations is due to a competitive interaction between PX and the divalent cation for membrane binding such that the divalent cations form an electrostatic interaction with the negative charges on the phospholipid head groups. These interactions between divalent cations and phospholipid head groups alter the ability of PX to form an electrostatic bond with the negatively charged phospholipid head groups.

A recent study on rabbit urinary bladder (2) demonstrated that addition of PX to the lumen increased the apical membrane conductance to small monovalent cations and anions. The increase in the membrane conductance by PX required that the membrane potential be cell interior negative, with the magnitude of the conductance change being an exponential function of the applied voltage. Such a sensitivity to membrane potential might explain why a molecule like PX is more toxic to Gram-negative bacteria than to mammalian cells. Exposure of the urinary bladder to low concentrations of PX for short times could be reversed by either clamping the epithelium such that the apical membrane potential was cell interior positive or by washing the PX out of the luminal bath. However, when the bladder was exposed, at cell interior negative potentials, to high concentrations of PX or for long periods of time (tens of minutes) PX caused an irreversible increase in the transepithelial conductance of the urinary bladder epithelium.

This study investigated whether divalent cations alter the ability of PX to increase the apical membrane conductance of the rabbit urinary bladder to PX. In brief, we show that divalent cations modify the PX-induced conductance (GPXt) not only by competitive interaction with a membrane binding site (a negatively charged phospholipid as suggested for bacteria; Ref. 23), but also by acting as an open-channel blocker (both Ca2+ and Mg2+) as well as by changing the rate at which the GPXt falls out of the membrane (fall out, only Ca2+). It is shown that PX requires both a positive charge and a fatty acid tail to increase the membrane conductance. Last, it is demonstrated that lowering luminal pH from 7.8 to 6.5 decreases the ability of PX to induce a membrane conductance by two of the above mechanisms.

    METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Urinary bladders were extracted from male New Zealand White rabbits. After removing the underlying smooth muscle layers (12), the epithelium was mounted between temperature-controlled modified Ussing chambers designed to reduce edge damage (13). The mucosal and serosal solutions were stirred by Teflon-coated magnetic spin bars driven by an external magnet coupled to a motor.

Solutions

The composition of the NaCl Ringer solution was (in mM) 111.2 NaCl, 25 NaHCO3, 10 glucose, 5.8 KCl, 2 CaCl2, 1.2 KH2PO4, and 1.2 MgSO4. The pH was adjusted to 7.4 while bubbling with 95% O2-5% CO2. For the KCl Ringer solutions, all Na+ salts were replaced with the corresponding K+ salts. Ca2+- and Mg2+-free Ringer solution was made by omitting the MgSO4 and replacing the CaCl2 with KCl. In the pH experiments, the solutions were buffered with K2CO3, and pH was adjusted using either 0.1 N H2SO4 or 0.6 N NaOH. For Ca2+ or Mg2+ dose-response experiments, aliquots were added from stock solutions of either CaCl2 or MgCl2 to achieve the final desired concentration. Unless otherwise stated, the serosal bathing solution was the NaCl Ringer solution, and the mucosal solution was the Ca2+/Mg2+-free KCl Ringer solution. Polymyxin sulfate (Fig. 1A) was obtained from Sigma Chemical (St. Louis, MO) and polymyxin nonapeptide (Fig. 1B) was obtained from Boehringer Mannheim (Indianapolis, IN). Both were made as concentrated stock solutions, and microliter quantities were added to the mucosal solution.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   A: structure of polymyxin B (PX). PX is a decapeptide with a fatty acid tail (R). The decapeptide has 6-diaminobutyric acid (DAB) molecules, and at pH 7.4, PX has 4.8 positive charges. F, phenylalanine; L, leucine; T, threonine. The fatty acid tail for polymyxin B1 is 6-methyloctanoyl and for polymyxin B2 is 6-methylheptanoyl. B: structure of PX nonapeptide (NP). NP has the same cyclic structure as PX but is missing the fatty acyl tail and one DAB molecule. This molecule has the same number of positive charges that PX has at a pH of 7.4.

Electrical Measurements

The transepithelial potential (Vt) was measured using Ag/AgCl wires or 1 M KCl agar bridges (when asymmetric chloride solutions were employed) placed close to and on opposite sides of the epithelium. The transepithelial resistance (Rt) or the transepithelial conductance (Gt = 1/Rt) was determined by passing a current through Ag/AgCl wires placed in the rear of each hemichamber and then measuring the transepithelial voltage change (Delta Vt). Both the current passing and the voltage recording electrodes were connected to an automatic current/voltage clamp (model EC-800LV; Warner Instruments, Hamden, CT).

The current and voltage outputs of the clamp were connected via a variable gain amplifier (model LPF-202; Warner Instruments) to an analog-to-digital converter (model PP-50 LAB; Warner Instruments), which was interfaced to a computer. These parameters were digitized, stored on hard disk, and logged on a printer along with the time of data acquisition and the calculated values for Rt, Gt, and short-circuit current (Isc). During open-circuit conditions Isc Vt/Rt. Data acquisition was at a maximum rate of five per second. In addition, Vt and I were continuously monitored on an oscilloscope and paper strip-chart recorder.

Current-Voltage Relationship

Current-voltage relationships (I-V) were generated while the transepithelial voltage was clamped at a potential of either 0 or -70 mV. Twenty stepped pulses of 50-ms duration were taken at 10-mV increments centered on either side of the clamped potential. A control I-V was done before PX was added to the mucosal bath. PX was then allowed to induce a conductance and then washed out of the mucosal bathing solution before the experimental I-V. A difference I-V was calculated by subtracting the control current values from the experimental current values at each of the voltage increments. The site of PX action was shown to be at the apical membrane (2); therefore, this subtraction yields the current flowing through the GPXt in the apical membrane. The ionic selectivity of the induced conductance was then determined by curve fitting the current-form of the constant-field equation to the data.

Standard Protocol

Unless otherwise noted, the standard experimental protocol was as follows. The Vt was first clamped at -70 mV (serosa ground), and then 400 U/ml (~36 µM) of PX was added to the mucosal bathing solution (a Ca2+/Mg2+-free KCl Ringer solution). After a 5-min incubation period, Vt was clamped from -70 mV to 0 mV, and the change in the transepithelial conductance (Delta Gt) was monitored.

Statistics

Data are expressed as means ± SE. Either paired or unpaired Student's t-tests or one-way ANOVAs were used to determine significance. Theoretical curves were fit to the data using a computer and either the nonlinear curve fitting routine NFIT (Island Products, Galveston, TX), orSCIENTIST (Micromath Scientific Software, Salt Lake City, UT) software for solving complex kinetic models.

    RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

In this section, it is first demonstrated that the magnitude of the increase in the transepithelial conductance by PX is dependent upon the luminal Ca2+ and Mg2+ concentrations. Then it is shown that the modulation of the PX-induced conductance by divalent cations occurs by at least two different mechanisms. Next, it is demonstrated that both the positive charge and the fatty acid tail of PX are required to increase the transepithelial conductance. Last, the effects of protons on the PX-induced conductance are studied.

Effect of Divalent Cations on PX-induced Conductance

Previous studies have demonstrated that divalent cations were potent blockers of cationic protein-induced conductance changes (22). Figure 2 demonstrates that the dose-response curves for PX are shifted to the right as the luminal Ca2+ concentration is increased. Thus luminal Ca2+ seems to competitively inhibit the ability of PX to induce a membrane conductance. At a constant luminal PX concentration and an increasing luminal Ca2+ or Mg2+ concentration, there is a decrease in the ability of PX to induce an increase in Gt (Fig. 3, A and B).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of luminal Ca2+ on the ability of PX to increase transepithelial conductance (Gt). In this experiment PX was added to the luminal solution (with a Ca2+ concentration of 0 mM, 2 mM, or 10 mM) when transepithelial potential (Vt) was clamped at -70 mV. After a 5-min incubation period, Vt was clamped to 0 mV, and the change in PX-induced conductance (Delta GPXt) was calculated. Note that when the bath contained 2 and 10 mM Ca2+, it took 5 and 20 times the concentration of PX to achieve the same Delta GPXt as in the nominally Ca2+ free bath. These results suggest that the interaction between PX and Ca2+ is competitive.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   A: effect of luminal Ca2+ on Delta GPXt. Experimental protocol was to add 400 U/ml of PX to a Ca2+/Mg2+-free luminal solution when Vt was clamped at -70 mV. After a 5-min incubation, Vt was clamped to 0 mV, and the Delta GPXt was calculated. Next, Vt was clamped to -70 mV, and the luminal calcium concentration was increased. After a 5-min incubation, Vt was again clamped to 0 mV, and the Delta GPXt was calculated. The smooth curve through the points was fit by hand. B: effect of increasing luminal Mg2+ on Delta GPXt when the tissue was clamped from -70 mV to 0 mV. Experimental protocol was similar to that described for Ca2+. The smooth curve through the points was fit by hand.

Three potential mechanisms by which divalent cations might inhibit the ability of PX to increase the membrane conductance are: 1) block of the conductance once it has been induced (conductive block), 2) increase the rate of loss of the conductance from the membrane (increase the rate of fall out), and 3) competitive interaction with the protein for a membrane binding site.

Conductive block. To investigate conductive block, the standard protocol was used. Once Gt had increased by 100-200 µS/cm2, the PX was washed from the luminal solution. In the absence of bath Ca2+, the loss of the PX-induced conductance is slow (see below). Next, the luminal concentration of Ca2+ or Mg2+ was increased in a step-wise manner, and the resulting steady-state conductance was measured. Following the step-wise additions and subsequent washout of the divalent cation, 67 ± 10% of the conductance decrease was recovered after Ca2+ addition, and 73 ± 11% was recovered after Mg2+ addition. Thus the Ca2+- or Mg2+-dependent decrease in conductance was reversible. Figure 4, A and B, shows the dose-response curves for Ca2+ and Mg2+ respectively. The data were fit by the sum of the Hill equation plus a divalent cation-insensitive PX-induced conductance (GiX). The best fit values are shown in Table 1. Ca2+ blocked all of the PX-induced conductance, whereas Mg2+ only partially blocked the PX-induced conductance. Addition of 10 mM Ca2+ blocked the remainder of the Mg2+-insensitive component of the GPXt (data not shown). The above data suggest that there could be at least two places for conductive block and that Ca2+ can act at both, whereas Mg2+ only acts at one.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   A: effect of luminal Ca2+ concentration on GPXt. Experimental protocol was to add PX to the Ca2+/Mg2+-free mucosal bathing solution of a tissue clamped at -70 mV, incubate for 5 min, and voltage clamp the tissue to 0 mV. Conductance was allowed to increase, and the PX was then washed out of the lumen. Increments of Ca2+ were added to the luminal solution in a stepwise manner. The resulting decrease in GPXt by Ca2+ was then fit by the Hill equation. The best fit Ki was 0.56 ± 0.18 mM, and N was 1.02 ± 0.1 (n = 4). Ca2+ inhibited all of the GPXt. B: effect of luminal Mg2+ concentration on the GPXt. Experimental protocol was similar to that for Ca2+, except luminal Mg2+ was increased. The resulting decrease in GPXt by Mg2+ was fit by the Hill equation. The best fit Ki was 0.37 ± 0.16 mM (n = 5), and the Hill coefficient was 0.68 ± 0.02. Magnesium only blocked 44 ± 6% of the GPXt.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Block of GPXt by divalent cations

Rate of reversal. The experimental protocol for investigating the ability of divalent cations to reverse the GPXt was as follows. After Gt had increased by 100-200 µS/cm2 using the standard protocol, PX was washed out of the luminal compartment, and the time-dependent change in conductance was monitored. A kinetic model to describe the time course of the change in GPXt is shown below.


View larger version (308K):
[in this window]
[in a new window]
 

where GPXp is the value for the bath and membrane-associated (bound) PX (which can either be washed out of the bath or become active) at the beginning of the mucosal solution wash, GPX-At is the active GPXt present at the beginning of the mucosal wash, and GPX-St is the stable GPXt. This latter conductance is not removed from the membrane after washing PX out of the mucosal bath. It can, however, be removed by clamping back to -70 mV (data not shown) or by adding a divalent cation to the mucosal bath. kpool Gtright-arrow active Gt (kpa) is the rate constant for the formation of an active conductance from the bath and membrane-associated PX, kactive Gtright-arrow out of membrane (kao) is the rate constant for the loss of GPX-At from the membrane, kactive Gtright-arrow stable Gt (kas) is the rate constant at which GPX-At is transformed to GPX-St (the stable form of the GPXt), and kpool Gtright-arrow out of bath (kpo) is the rate constant for washout of PX from the mucosal bath. The equation that describes the time-dependent change in GPXt during the wash of PX from the mucosa, GPXt(t), is

<IT>G</IT> <SUP>PX</SUP><SUB>t</SUB>(<IT>t</IT>) = <FR><NU><IT>G</IT> <SUP>PX</SUP><SUB>p</SUB>(0)<IT>k</IT><SUB>pa</SUB></NU><DE><IT>k</IT><SUB>as</SUB> + <IT>k</IT><SUB>ao</SUB> − <IT>k</IT><SUB>pa</SUB> − <IT>k</IT><SUB>po</SUB></DE></FR> <IT>e</IT><SUP>−<IT>t</IT>(<IT>k</IT><SUB>pa</SUB>+<IT>k</IT><SUB>po</SUB>)</SUP>
+ <FR><NU><IT>G</IT> <SUP>PX</SUP><SUB>p</SUB>(0)<IT>k</IT><SUB>pa</SUB> + <IT>G</IT> <SUP>PX-A</SUP><SUB>t</SUB>(0)(−<IT>k</IT><SUB>as</SUB> − <IT>k</IT><SUB>ao</SUB> + <IT>k</IT><SUB>pa</SUB> + <IT>k</IT><SUB>po</SUB>)</NU><DE>−<IT>k</IT><SUB>as</SUB> − <IT>k</IT><SUB>ao</SUB> + <IT>k</IT><SUB>pa</SUB> + <IT>k</IT><SUB>po</SUB></DE></FR> <IT>e</IT><SUP>−<IT>t</IT>(<IT>k</IT><SUB>as</SUB>+<IT>k</IT><SUB>ao</SUB>)</SUP>
+ <FR><NU><IT>k</IT><SUB>as</SUB><IT>k</IT><SUB>pa</SUB><IT>G</IT> <SUP>PX</SUP><SUB>p</SUB>(0) + (<IT>k</IT><SUB>pa</SUB> + <IT>k</IT><SUB>po</SUB>)<IT>k</IT><SUB>as</SUB><IT>G</IT> <SUP>PX-A</SUP><SUB>t</SUB>(0) + (<IT>k</IT><SUB>pa</SUB> + <IT>k</IT><SUB>po</SUB>)(<IT>k</IT><SUB>ao</SUB> + <IT>k</IT><SUB>as</SUB>)<IT>G</IT> <SUP>PX-S</SUP><SUB>t</SUB>(0)</NU><DE>(<IT>k</IT><SUB>ao</SUB> + <IT>k</IT><SUB>as</SUB>)(<IT>k</IT><SUB>pa</SUB> + <IT>k</IT><SUB>po</SUB>)</DE></FR>
+ <FR><NU><IT>k</IT><SUB>pa</SUB><IT>k</IT><SUB>as</SUB><IT>G</IT> <SUP>PX</SUP><SUB>p</SUB>(0)</NU><DE>(-<IT>k</IT><SUB>pa</SUB> − <IT>k</IT><SUB>po</SUB>)(−<IT>k</IT><SUB>pa</SUB><IT>k</IT><SUB>po</SUB> + <IT>k</IT><SUB>ao</SUB> + <IT>k</IT><SUB>as</SUB>)</DE></FR> <IT>e</IT><SUP>−<IT>t</IT>(<IT>k</IT><SUB>pa</SUB>+<IT>k</IT><SUB>po</SUB>)</SUP>
+ <FR><NU><IT>k</IT><SUB>as</SUB><IT>k</IT><SUB>pa</SUB><IT>G</IT> <SUP>PX</SUP><SUB>p</SUB>(0) + (−<IT>k</IT><SUB>ao</SUB> − <IT>k</IT><SUB>as</SUB> + <IT>k</IT><SUB>pa</SUB> + <IT>k</IT><SUB>po</SUB>)<IT>k</IT><SUB>as</SUB><IT>G</IT> <SUP>PX-A</SUP><SUB>t</SUB>(0)</NU><DE>(−<IT>k</IT><SUB>ao</SUB> − <IT>k</IT><SUB>as</SUB>)(−<IT>k</IT><SUB>ao</SUB> − <IT>k</IT><SUB>as</SUB> + <IT>k</IT><SUB>pa</SUB> + <IT>k</IT><SUB>po</SUB>)</DE></FR> <IT>e</IT><SUP>−<IT>t</IT>(<IT>k</IT><SUB>ao</SUB>+<IT>k</IT><SUB>as</SUB>)</SUP> (1)



During curve fitting, there are only two adjustable parameters, i.e., kao (the rate constant for loss of the active conductance from the membrane) and kas (the rate constant at which the active conductance is transformed into a stable conductance in the membrane). When fitting Eq. 1 to the data, kpo was held constant at 0.083 s-1 (an estimate), and the value of GPXp(0) was calculated as the rate of conductance change measured immediately before the start of the mucosal wash divided by kpa. The rate constant kpa was set at a value 1,000-fold lower than kpo; i.e., it was assumed that formation of the GPXt did not significantly alter the bath PX concentration. GPX-At was set equal to the GPXt at the start of the wash. The smooth curve through the data in Fig. 5 is the best fit of Eq. 1 to a representative data set in a Ca2+- and Mg2+-free KCl Ringer solution. The best fit value for kao was 0.026 ± 0.002 s-1 and for kas was 0.006 ± 0.001 s-1 (n = 20). In the absence of bath Ca2+ and Mg2+, ~20% of the total GPX-At (i.e., the GPX-At at time 0 as well as the fraction of GPXp that was converted into GPX-At) entered the stable state. In contrast, in the presence of 2 mM Ca2+ and 1.2 mM Mg2+ in the KCl Ringer solution, the best fit value for kao was 0.014 ± 0.004 s-1 and for kas was 0.00005 ± 0.0002 s-1 (n = 18). Thus, in the presence of bath Ca2+ and Mg2+, the rate for loss of the active conductance, kao, is ~54% slower than in the absence. The rate constant at which the active conductance is transformed into a stable conductance in the presence of bath Ca2+ and Mg2+ is reduced to a value not statistically different from zero. The section below will investigate the influence of Ca2+ and Mg2+ on these two rate constants.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 5.   Time course of the change in the Gt after washing PX out of the luminal solution. PX was added to the mucosal bath while the tissue was clamped at -70 mV and incubated for 5 min. Tissue was then clamped to 0 mV, and the Gt was allowed to increase by 50-100 µS. PX was then washed out of the bath (while clamped at 0 mV), and the change in Gt was measured over time. Smooth curve through the data points is the best fit of Eq. 1 to the data. For this example the rate constant for the loss of GPX-At from the membrane (kao) = 0.04 s-1, and the rate constant at which GPX-At is transformed to GPX-St (the stable form of the GPXt) (kas) = 0.01 s-1.

DEPENDENCE OF REVERSAL ON CALCIUM. The effect of luminal Ca2+ on the reversal of the GPXt was studied using the protocol for reversal described above. The best fit values for kao and kas as a function of luminal Ca2+ are shown in Fig. 6A. Of interest is that increasing luminal Ca2+ concentration caused a decrease in kao. The values for kas at 1, 2, and 10 mM Ca2+ concentrations were not statistically different from zero; however, the kas value for 0 Ca2+ is significantly different from 0. This suggests that luminal Ca2+ inhibits the formation of the stable form of the conductance.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 6.   A: rate constants, kao (bullet ) and kas (open circle ), as a function of the luminal Ca2+ concentration were obtained by fitting Eq. 1 to the data. An increase in the Ca2+ concentration caused a decrease in the kao, indicating that the presence of Ca2+ slowed the process of GPX-At leaving the membrane. The increase in kao from 2 to 10 mM Ca2+ was not significant. The kas values were not significantly different from 0 except at 0 mM Ca2+ concentration, suggesting that luminal Ca2+ inhibits the formation of the stable conductance. B: rate constants, kao (bullet ) and kas (open circle ), as a function of the luminal Mg2+ concentration. These values were obtained in the same manner as for Ca2+. Luminal Mg2+ did not decrease kao or kas.

DEPENDENCE OF REVERSAL ON MAGNESIUM. The effect of Mg2+ on reversing the GPXt was studied in a manner identical to that for Ca2+. The time course of the conductance change from the initiation of mucosal wash was curve fit by Eq. 1. Figure 6B shows the effect of increasing luminal Mg2+ on kao and kas. Of interest is that Mg2+ did not alter the rate at which GPX-At entered the stable state GPX-St, nor did it decrease the rate at which the GPXt left the membrane.

Binding site. To investigate a possible interaction of these divalent cations at a membrane binding site, the measured Delta GPXt in the presence of divalent cations must be corrected for the rate of fall out as well as conductive block. Since the rate constant for loss of GPX-At (kao) is slow compared with the time period over which Delta GPXt is measured, fall out will not significantly alter the magnitude of Delta GPXt. The Delta GPXt can be reduced to two components, the conductance formation and the conductive block. Using the relationship between divalent cation concentration and conductive block (Fig. 4), the Delta GPXt (Fig. 3) was corrected for the conductance that was being blocked by the divalent cation, and this corrected conductance is Delta GPXt(X).

A kinetic model was developed to describe the binding of PX to the membrane binding site in the presence of divalent cations to determine the dissociation constant for Ca2+ and Mg2+ to the membrane binding site.


View larger version (7K):
[in this window]
[in a new window]
 

where S is an unoccupied membrane binding site, B is a binding site that has been bound by a divalent cation and is unavailable to bind a PX molecule, and O is a binding site that has been bound by PX and has formed a conductance. KCa,Mgleft-right-arrow binding site (Ki) is the dissociation constant for either Ca2+ or Mg2+ for the binding site, and KPXleft-right-arrow binding site (KPX) is the dissociation constant for PX for the binding site. The equation that describes the divalent cation effects on the Delta GPXt is as follows
&Dgr;<IT>G</IT><SUP>PX</SUP><SUB>t</SUB>(X) = <FR><NU>&Dgr;<IT>G</IT> <SUP>PX</SUP><SUB>t</SUB>(max X)</NU><DE><FR><NU><IT>K</IT><SUB>PX</SUB>[X]</NU><DE><IT>K</IT><SUB>i</SUB>[PX]</DE></FR> + <FR><NU><IT>K</IT><SUB>PX</SUB></NU><DE>[PX]</DE></FR> + 1</DE></FR> (2)
Delta GPXt(max X) is the maximum rate of increase of the GPXt in Ca2+- and Mg2+-free solution, [X] and [PX] are the concentrations of the divalent cation and PX, respectively, and KPX and Ki are dissociation constants as previously described in the kinetic scheme. The normalized data sets, corrected for conductive block as described above, were fit by Eq. 2. The means of the fit values for the data set are shown in Table 2. Figure 7, A and B, shows the relationship of the Delta GPXt, which has been corrected for block as a function of the divalent concentration.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Effects of divalent cations on Delta GPXt(X)


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 7.   A: effect of luminal Ca2+ on the Delta GPXt, which has been corrected for conductive block. The data from Fig. 3 were corrected for block. These data were fit by Eq. 2. Smooth curve was generated from the mean of the best fit values from these data sets. See Table 2 for best fit values. B: effect of luminal Mg2+ on the Delta GPXt, which has been corrected for block. Data and curve fitting were treated identically to that for Ca2+. See Table 2 for best fit values.

Given the ability of Ca2+ and Mg2+ to alter Delta GPXt, we determined the selective permeability (using I-V relationships, see METHODS) to Cl-, K+, and Na+ of the GPXt in Ca2+- and Mg2+-containing Ringer solution, in Ca2+-free, Mg2+-containing Ringer solution, and in Ca2+- and Mg2+-free Ringer solution. The concentration of PX was adjusted among these conditions such that the GPXt was similar. Table 3 shows that the selective permeability of the GPXt to Cl-, K+, and Na+ was not altered by the presence or absence of either Ca2+ or Mg2+. This suggests that the induced conductance is of a uniform type, since blocking some of the conductance does not affect the ion flow through the remainder of the induced conductance.

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Ion selectivity of the PX-induced conductance

Effects of Structural Components of PX

PX is composed of two domains, i.e., a hydrophilic cyclic heptapeptide with a tripeptide side chain coupled to a lipophilic fatty acid tail (see Fig. 1A). In this section, we address the question of whether the fatty acid tail is required for PX to increase the Gt. PX nonapeptide (see Fig. 1B) is PX that lacks the fatty acid tail and terminal diaminobutyric acid.

The addition of up to 185 µM of nonapeptide (5 times the amount of PX on a mole:mole basis) to the luminal Ca2+/Mg2+-free KCl Ringer solution did not alter Gt when Vt was clamped from -70 mV to 0 mV (data not shown). Preincubation of the tissue with nonapeptide did not change the ability of PX to increase Gt, as shown in Table 4. This not only suggests that PX is inactive in the absence of the fatty acid tail but also that nonapeptide is not competing for a binding site with PX.

                              
View this table:
[in this window]
[in a new window]
 
Table 4.   Effect of nonapeptide on transepithelial conductance

Proton Effects on GPXt

To study the relationship between the number of positive charges on PX and the ability of PX to induce a conductance, the mucosal solution pH was varied from 6.0 to 9.8. Since the proton concentration of the mucosal bathing solution was varied, we also investigated other effects that protons might have on the GPXt. Specifically, we investigated the possibility that protons might act as conductive blockers, alter the fall out rate, or compete for a membrane binding site.

Figure 8A is a titration curve for PX and demonstrates that PX has a pKa of 8.8, i.e., at pH 8.8, PX will have on average 2.5 charges. Changing the pH on either side of this pK value would change the number of charges on the PX molecule, providing an opportunity to determine the effects (if any) of charge on the ability of PX to induce a conductance. The protocol for this experiment was as follows. The pH of the luminal solution was adjusted to pH 9.8 in a Ca2+/Mg2+-free KCl Ringer solution, and Vt was clamped at -70 mV. After a 5-min incubation with PX, Vt was clamped to 0 mV and the Delta GPXt was measured. Gt was clamped back to -70 mV, and the conductance was allowed to recover to the baseline value. The pH of the solution was decreased by the addition of HCl (the pH was monitored by a pH electrode in the luminal compartment). After 5 min at the lowered pH, Vt was clamped to 0 mV and the Delta GPXt was measured. As shown in Fig. 8B, as the luminal pH was decreased from 9.8, the Delta GPXt increased up to a pH of 7.8. However, as the pH decreased below 7.8, the Delta GPXt also decreased.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 8.   A: titration curve for 250 µM PX. Peak in the curve yields a pKa for PX of 8.8, which is a Ka of 1.6 nM. B: effect of charge of the PX molecule on Delta GPXt. Delta GPXt was normalized to the conductance change at pH 7.7. A minimum of three charges is required to produce a measurable Delta GPXt. Delta GPXt reached a maximum at a pH of 7.8. A further decrease in luminal pH resulted in a decrease in Delta GPXt. Solid circles, Delta GPXt values that have not been corrected for conductive block. Solid line, best fit of Eq. 3 to the uncorrected data. In this example, the best fit values for the uncorrected data are Delta GPXt(max H+) (the maximum Delta GPXt at a proton concentration of 0) = 6.27 and Ksh (the dissociation constant for a proton to the binding site) = 23 nM. Open circles, Delta GPXt values that have been corrected for conductive block. Dashed curve, best fit of Eq. 3 to the corrected data. In this example, the best fit values are Delta GPXt(max H+) = 5.5 and Ksh = 50 nM.

To determine whether the increase in Delta GPXt when changing pH from 9.8 to 7.8 was due to the number of charges on the PX molecule and not to a pH-dependent alteration of the luminal membrane, the same experiment was performed using protamine sulfate (PS). Protamine is a cationic protein of 4,000 Da, is composed of 67% arginine, and has been shown to induce a conductance in apical membrane of the urinary bladder (20, 21). Guanidinium is the residue that gives arginine a net positive charge and has a pK of 12.5. Thus the net charge on protamine will be constant over the pH range studied (i.e., pH 9.8 to 7.8). There was no effect of pH from 9.8 to 7.8 on the ability of PS to induce a membrane conductance (data not shown). Thus pH over this range does not seem to alter the properties of the luminal membrane.

The possible effects of protons on the PX-induced conductance were studied in a manner similar to that for divalent cations.

Conductive block. To determine how much of the induced conductance was being blocked by protons, we added PX to the luminal compartment. The pH of the Ca2+/Mg2+-free, carbonate-buffered KCl Ringer solution was adjusted to 8.2 while Vt was clamped to -70 mV. After a 5-min incubation, Vt was clamped to 0 mV, and the conductance was allowed to increase to a maximum of 200 to 300 µS/cm2. The mucosa was then washed with a PX-free solution of pH 8.2. After the transepithelial conductance reached a steady state, the mucosal bathing solution pH was decreased (in a stepwise manner) using predetermined aliquots of 1.8 mM H2SO4. After the luminal solution had been titrated to a pH value of 6.0, the mucosal pH was returned to 8.2 to determine whether the conductance loss was reversible. In these experiments, 91.5 ± 21% (n = 6) of the conductance was recovered. The resultant conductance change was determined for each pH value, and the normalized data were fit by the sum of the Michaelis-Menten equation plus a proton-insensitive PX-induced conductance (GiH+). Figure 9 shows the concentration-conductance relationship for protons. The best fit values are as follows (n = 6): GPXt(max bH+) = 0.57 ± 0.13, KbH+ = 55.7 ± 10.8 nM (equivalent to a pH of 7.25), and GiH+ = 0.49 ± 0.13. Thus about half of the induced conductance is not blocked by protons. Since the dissociation constant for proton conductive block is a pH of 7.25, the increase in the rate of PX-induced conductance as pH is decreased from 9.8 to 7.8 cannot be accounted for by release from conductive block. These data suggest that most of the change over the pH range of 7.8 to 9.8 must be due to the charge on the PX molecule.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 9.   Effect of protons on the GPXt. In this experiment PX was added to the mucosal chamber of a tissue clamped at -70 mV and bathed in a Ca2+/Mg2+-free solution. After a 5-min incubation, Vt was clamped to 0 mV, and Gt was allowed to increase 100-200 µS before the PX was removed by wash. When a steady-state Gt was reached, the pH of the solution was lowered in a stepwise fashion, and the Gt was monitored. Resultant decrease in GPXt was fit by the Michaelis-Menten equation plus a constant (GiH+; the GPXt that was not blocked by protons). Best fit values are as follows: KbH+ (the dissociation constant for proton conductive block) = 55.7 ± 10.8 nM (pH of 7.25) and GiH+ = 0.49 ± 0.13. Maximum fraction of GPXt that protons blocked [GPXt(max bH+)] was 0.57 ± 0.13 (n = 6). Thus 54% of the GPXt was blocked by protons.

Rate of reversal. The effect of protons on the rate of fall out was studied by adjusting the pH of a Ca2+/Mg2+-free, carbonate-buffered mucosal KCl solution to a predetermined pH value between 6.5 and 8.2. (Above 8.2 and below 6.5 PX did not induce enough of a conductance to study its fall out rate.) PX was added while Vt was clamped at -70 mV. After a 5-min incubation period, Vt was clamped to 0 mV. A conductance increase of ~200 µS/cm2 was induced before the mucosa was washed with a PX-free solution of the same pH. The resultant time-dependent conductance change was fit to Eq. 1 to determine the kao and kas values (see Table 5). Protons did not alter the kao (rate constant for the loss of the active conductance from the membrane i.e., fall out), nor did they alter kas (rate constant at which the active conductance is transformed into a stable conductance in the membrane). These data suggest that the decrease in the PX-induced conductance at an acidic pH is not due to an increased rate of fall out of the conductance.

                              
View this table:
[in this window]
[in a new window]
 
Table 5.   Effects of proton concentration on kao and kas

Binding site. The following kinetic model was developed to determine the proton dissociation constant for a membrane binding site


View larger version (11K):
[in this window]
[in a new window]
 

where S is an unoccupied binding site on the membrane that can either be bound by PX and form a conductance O or be bound by protons that will block the binding of PX and subsequent conductance formation. This bound site is designated as B. [PX0+] is the concentration of the uncharged form of PX, and [PX5+] is the concentration of the fully charged form of PX. The dashed arrows indicate protons binding to and unbinding from the PX molecule, indicating the presence of all charged forms of PX. The sum of the concentrations of the forms of PX, i.e., PX0+ + PX1+ + ... + PX5+ equals the total concentration of PX in the bath. [H+] is the concentration of protons that can affect the ability of PX to induce a conductance in two manners. First, by binding to the binding site(s) and preventing formation of a conductance and, second, by increasing the charge on the PX molecule, thereby increasing its effectiveness. KH+left-right-arrow PX molecule (Ka) is the dissociation constant of the proton binding to the PX molecule, KH+left-right-arrow binding site (Ksh) is the dissociation constant for a proton to the binding site, and KPX5+left-right-arrow binding site (KPX) is the dissociation constant for PX to the binding site. The equation that describes this proton-dependent Delta GPXt or Delta GPXt(H+) is
&Dgr;<IT>G</IT> <SUP>PX</SUP><SUB>t</SUB>(H<SUP>+</SUP>)
= <FR><NU>&Dgr;<IT>G</IT> <SUP>PX</SUP><SUB>t</SUB>(max H<SUP>+</SUP>)</NU><DE>1 + <FR><NU><IT>K</IT><SUB>PX</SUB></NU><DE>[PX]</DE></FR> <FENCE>1 + <FR><NU><IT>K</IT><SUB>a</SUB></NU><DE>[H<SUP>+</SUP>]</DE></FR></FENCE><SUP><IT>N</IT></SUP> + <FR><NU>[H<SUP>+</SUP>]<IT>K</IT><SUB>PX</SUB><FENCE>1 + <FR><NU><IT>K</IT><SUB>a</SUB></NU><DE>[H<SUP>+</SUP>]</DE></FR></FENCE><SUP><IT>N</IT></SUP></NU><DE><IT>K</IT><SUB>sh</SUB>[PX]</DE></FR></DE></FR> (3)
where Delta GPXt(max H+) is the maximum Delta GPXt at a proton concentration of 0, and [PX] is the concentration of PX (the sum of all the charged forms of PX, i.e., [PX0+], [PX1+], ... [PX5+]), which was held at 400 U/ml in these experiments. Ka, Ksh, and KPX are as explained above in Model 3. N was held at 5 during curve fitting; i.e., we assumed that PX had to be fully charged to induce a conductance. When fitting the data by Eq. 3, Ka was held at the value of the pK from the PX titration curve, pH of 8.8, or a proton concentration of 1.6 nM. KPX was held at the value of 735 U/ml determined from the PX concentration-conductance relationship (2). Using the relationship between proton concentration and conductive block (Fig. 9), the Delta GPXt(H+) (Fig. 8B, solid circles) was corrected for the conductance that was being blocked by protons. Thus only two parameters were varied Delta GPXt(max H+) and Ksh. The best fit value for Delta GPXt(max H+) was 8.6 ± 2.00 and for Ksh was 27.9 ± 7.49 nM or pH 7.6 (n = 6). This value represents the dissociation constant for protons to the binding site.

    DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

This section will review divalent cation and proton modulation of the GPXt by three mechanisms, conductive block, fall out rate, and competitive interaction with a binding site. The data will be discussed in terms of the structure of PX and its effects on cell membranes. The evidence for a binding site and its possible identity will be addressed. Finally, a model for PX conductance formation and modulation will be presented.

Modulation of PX Effects

It has been previously shown that PX can increase the apical membrane conductance of the rabbit bladder epithelium in a time-, voltage-, and concentration-dependent manner (2). We have investigated the dependence of this permeability increase on divalent cations and protons.

Divalent cations. The results from this study suggest that Mg2+ and/or Ca2+ modulated the PX-induced conductance increase by three mechanisms. First, Ca2+ and Mg2+ blocked the PX-induced conductance in a reversible manner (conductive block). Ca2+ completely blocked the induced conductance, whereas Mg2+ blocked only 44%. The Mg2+-insensitive conductance was blocked by the subsequent addition of Ca2+. Second, the addition of Ca2+ to the bathing solution slowed the loss of the PX-induced conductance from the membrane; however, Ca2+ was required for a complete removal of the conductance from the membrane. Mg2+ did not alter the fall out rate. Third, Ca2+ and Mg2+ compete with PX for a membrane binding site. The modulation by Ca2+ is in agreement with a previous study (22) of the cationic polypeptide PS. The voltage-dependent, PS-induced increase in the conductance of the rabbit bladder epithelium was also found to be modulated by Ca2+ and Mg2+.

Protons. This study also demonstrated that protons had a modulatory effect (both stimulatory and inhibitory) on the ability of PX to induce a membrane conductance. As the pH was changed from 9.8 to 7.8, the ability of PX to induce a conductance increased, whereas changing pH from 7.8 to 6.5 resulted in a decrease in the ability of PX to induce a conductance. This stimulatory effect of protons (at high pH) on the rate of formation of a PX-induced conductance was due to an increase in the number of charges on the PX molecule. The decrease in PX-induced conductance from pH 7.8 to 6.5 occurred by the same mechanisms as Ca2+ and Mg2+. Thus protons compete with PX for a membrane binding site and block (in a reversible manner) ~50% of the PX-induced conductance. As was found for Mg2+, protons did not alter the rate of loss of the PX-induced conductance from the membrane.

Identity of the Binding Site

The dose-response curves for PX (2) and divalent cations and proton competition studies suggest the existence of a membrane binding site. Studies on bacteria suggest that these binding sites probably consist of negatively charged lipid components (1, 8, 19), such as phosphatidylserine, which is also known to be present in the mamalian urinary bladder (10, 18). It has been proposed that Ca2+ and Mg2+ act as metal ion bridges between the negatively charged phosphate groups on phospholipid molecules as well as those on the lipopolysaccharide molecules in the outer leaflet of the outer membranes of Gram-negative bacteria (11). For PX to form a conductance in the membrane, the PX molecule would have to displace the Ca2+ or the Mg2+ from the membrane (23). Thus, in the absence of Ca2+, PX was more effective in forming a conductance, perhaps because it did not have to compete for a binding site on the phospholipid molecule with the Ca2+ ion. A competition between PX and Ca2+ binding has been shown in cultured neonatal rat myocardial cells (5), as well as in ram spermatozoa (3).

A number of systems indicate that PX binding is cooperative (9, 17). This cooperative binding probably explains the sigmoidal nature of the conductance increase reported by Berg et al. (2) as an alternative to the number of PX molecules required to form a conductive unit.

Structure-Function Studies of PX and Related Peptides

The PX molecule has two distinct structural domains. The first is a fatty acid tail with a length of seven or eight carbons. The tail is connected to the second domain, which is a tripeptide chain attached to a cyclic heptapeptide head (see Fig. 1A). This second domain contains a maximum of five positive charges. When PX nonapeptide (PX without the fatty acid tail) was added to the mucosal solution of the rabbit urinary bladder there was no change in the conductance of the tissue. If the pH of the solution was raised to a point where the amino groups on the PX molecule were expected to be uncharged, then, again, there was no increase in the conductance of the tissue. These data suggest the need for both the fatty acid tail and the positive charges to induce a conductance.

Fatty acid tail. Addition of nonapeptide (at 5 times the molar concentration of PX) did not affect the tissue conductance. This indicates that without the fatty acid tail, this concentration of nonapeptide cannot form a conductance in the urinary bladder epithelium. In a study by Duwe et al. (7), a 51Cr release assay was used to determine the effectiveness of the nonapeptide and PX against a chronic myelogenous human leukemia cell line (K-562). It was found that at concentrations as low as 50 µg/ml of PX, there was a 21.6% 51Cr release, whereas at concentrations of nonapeptide as high as 3 mg/ml there was a minimal 51Cr release. In addition, the cells exposed to nonapeptide remained healthy over a period of 48 h as determined by morphological assessment and trypan blue exclusion. Using lipid bilayers, Schroder et al. (16) demonstrated that PX-induced single channel-like events, whereas nonapeptide at similar concentrations did not alter the bilayer membrane conductance. Taken together the above observations suggest that the fatty acid tail enhances the ability of PX to increase membrane conductance.

If PX and nonapeptide share the same binding site, then a reduction in the magnitude of the PX-induced conductance due to competition by nonapeptide might be predicted. Our results suggest that there was no effect on the PX-induced conductance when the epithelium was concomitantly treated with PX and up to five times its molar concentration of nonapeptide. A possible explanation is that the affinity of PX compared with the nonapeptide for a membrane binding site is potentiated by the presence of the PX hydrophobic tail. Buser et al. (6) have studied the effect of a fatty acid tail (myristol, 14 carbon tail) on the affinity of a cationic peptide (residues 2-16 of the Src protein) to charged lipid vesicles. These authors demonstrated that the myristylated cationic peptide binds four orders of magnitude more strongly to anionic phospholipid vesicles than the nonmyristylated cationic peptide. If the acyl tail of PX increases the affinity of PX compared with nonapeptide by a similar amount, then the concentration of nonapeptide would have to be many-fold higher (around 1,000 to 10,000) than that of PX before there would be a significant decrease in the ability of PX to induce a conductance. It is apparent that in both bacteria (24) and in urinary bladder epithelium that the fatty acid tail is needed to affect the cells in a lethal manner.

Positive charge. In addition to requiring the fatty acid tail domain, the necessity of a net positive charge for PX to induce a conductance was described. It is clear that as the pH of the solution was lowered from a value of 9.8, the ability of PX to induce a conductance increased (see Fig. 8B). This rate of conductance increase coincides with the increase in the number of charges on the PX molecule as determined from our titration study and the reported buffer capacity of PX (4). In a study of the susceptibility of Escherichia coli lipid liposomes containing glucose, a similar polymyxin response to pH was observed (8). As the pH was lowered from 10.5 to 7.8, the amount of polymyxin-induced glucose release increased. As the pH was lowered past 7.8, the amount of glucose released decreased. These data demonstrate the necessity of the charged portion of the molecule not only for conductance formation in the bladder but also for bactericidal action.

Model of PX Action on Bladder Epithelium

A model for the formation of a conductance by PX in the apical membrane needs to contain the following features (as reported in a previous study; Ref. 2): 1) a membrane binding site as suggested by the saturating concentration-conductance relationship, 2) the time-dependent formation of the conductance has a concentration and voltage-dependent lag phase, 3) voltage and wash-off-dependent reversibility; as well as (from the present study), 4) the necessity of the fatty acid tail as evidenced by the experiments with PX nonapeptide, 5) the necessity of a positively charged decapeptide with a cyclic heptapeptide head, 6) competition for the binding site by both protons and divalent cations, 7) conductive block by both protons and divalent cations, and 8) Ca2+-dependent fall out of the conductance from the membrane,

A tentative description of a model for the formation of a polymyxin-induced conductance is as follows. At a cell interior positive voltage, PX will associate with a membrane binding site but not induce a conductance. This association is composed of the insertion of the fatty acid tail of the polymyxin molecule into the cell membrane as well as the electrostatic interaction of the positive charges on the molecule with a negatively charged membrane binding site. Mg2+, Ca2+, and H+ can bind to the membrane binding sites and inhibit the formation of a conductance by PX. Once PX has associated with the membrane, it remains inactive until a cell interior negative voltage is applied. When this negative voltage is applied, the PX molecules move into the membrane forming, by an unknown mechanism, a conductive "pore." The lag phase in the conductance formation might be due to the time it takes the molecules to move into the membrane to the conductive configuration. The greater the PX concentration or the more negative the cell interior voltage, the greater will be the induced conductance and the shorter the lag phase of the induced conductance.

The reversibility of the polymyxin-induced conductance (in the absence of bath Ca2+) suggests that two types of conductances are formed, i.e., a stable and an unstable conductance. The unstable conductance (but not stable conductance) can be removed from the membrane by washing PX from the mucosal bath. This unstable conductance does not form in the presence of Ca2+. The stable conductance is defined as the PX-induced conductance that remains after PX is washed from the bath in the presence of a cell interior negative voltage. This stable conductance is blocked by divalent cations and protons. In addition, it can fall out of the membrane in the absence of Ca2+ when the voltage is at -70 mV and bath PX has been removed. This stable conductance can also be removed from the membrane (independent of voltage) by the addition of mucosal Ca2+ but not by Mg2+ or H+.

Studies are presently underway to determine how many different types of conductive units PX can form, whether these units are formed in a parallel or serial manner, and the influence of the type of lipid on the properties of the PX-induced conductance.

    ACKNOWLEDGEMENTS

We thank Dr. G. Boyarsky, for helpful discussions concerning pH, and Dr. S. King, for reading a preliminary version of this study.

    FOOTNOTES

This research was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-51382 to S. A. Lewis.

Address reprint requests to S. A. Lewis.

Received 22 December 1997; accepted in final form 8 April 1998.

    REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

1.   Bader, J., and M. Z. Teuber. Binding to the O-antigenic lipopolysaccharide of Salmonella typhimurium. Naturforsch Teil. C 28: 422-430, 1973.

2.   Berg, J. R., C. M. Spilker, and S. A. Lewis. Effects of polymyxin B on the mammalian urinary bladder. J. Membr. Biol. 154: 119-130, 1996[Medline].

3.   Bradley, M. P., D. G. Rayns, and I. T. Forrester. Effects of filipin, digitonin, and polymyxin B on plasma membrane of ram spermatozoa: an EM study. Arch. Androl. 4: 195-204, 1980[Medline].

4.   Brintzinger, H. Die wechselwirkung von polymyxin B mit zweiwertigen kationen in wäasseriger lösung. Helv. Chim. Acta 44: 744-753, 1961.

5.   Burt, J. M., and G. A. Langer. Ca2+ displacement by polymyxin B from sarcolemma isolated by gas dissection from cultured neonatal rat myocardial cells. Biochim. Biophys. Acta 729: 44-52, 1983[Medline].

6.   Buser, C. A., C. T. Sigal, M. D. Resh, and S. McLaughlin. Membrane binding of myristylated peptides corresponding to the NH2 terminus of Src. Biochemistry 33: 13093-13101, 1994[Medline].

7.   Duwe, A. K., A. Rupar, G. H. Horsman, and S. I. Vas. In vitro cytotoxicity and antibiotic activity of polymyxin B nonapeptide. Antimicrob. Agents Chemother. 30: 340-341, 1986[Abstract/Free Full Text].

8.   Feingold, D. S., C. C. HsuChen, and I. J. Sud. Basis for the action of the polymyxin antibiotics on cell membranes. Ann. NY Acad. Sci. 235: 480-492, 1974[Medline].

9.   Hartmann, W., H.-J. Galla, and E. Sackmann. Polymyxin binding to charged lipid membranes an example of cooperative lipid-protein interaction. Biochim. Biophys. Acta 510: 124-139, 1978[Medline].

10.   Ketterer, B., R. M. Hicks, L. Christodoulides, and D. Beale. Studies of the chemistry of the luminal plasma membrane of the rat bladder epithelial cells. Biochim. Biophys. Acta 311: 180-190, 1973[Medline].

11.   Lieve, L. The barrier function of the Gram-negative envelope. Ann. NY Acad. Sci. 235: 109-129, 1974[Medline].

12.   Lewis, S. A., and J. M. Diamond. Na+ transport by rabbit urinary bladder, a tight epithelium. J. Membr. Biol. 28: 1-40, 1976[Medline].

13.   Lewis, S. A., D. C. Eaton, C. Clausen, and J. M. Diamond. Nystatin as a probe for investigating the electrical properties of a tight epithelium. J. Gen. Physiol. 70: 427-440, 1977[Abstract/Free Full Text].

14.   Lewis, S. A., and N. K. Wills. Resistive artifacts in liquid-ion exchanger microelectrodes estimates of Na2+ activity in epithelial cells. Biophys. J. 31: 127-138, 1980[Medline].

15.   Lewis, S. A., N. K. Wills, and D. C. Eaton. Basolateral membrane potential of a tight epithelium: Ionic diffusion and electrogenic pumps. J. Membr. Biol. 41: 117-148, 1978[Medline].

16.   Schroder, G., K. Brandenburg, and U. Seydel. Polymyxin B induces transient fluctuations in asymmetric planar lipopolysaccharide/phospholipid bilayers. Biochemistry 31: 631-638, 1992[Medline].

17.   Sixl, F., and H.-J. Galla. Cooperative lipid-protein interaction Effect of pH and ionic strength on polymyxin binding to phosphatidic acid membranes. Biochim. Biophys. Acta 557: 320-330, 1979[Medline].

18.   Stubbs, C. D., B. Ketterer, and R. M. Hicks. The isolation and analysis of the luminal plasma membrane of calf urinary bladder epithelium. Biochim. Biophys. Acta 558: 58-72, 1979[Medline].

19.   Teuber, M., and I. R. Miller. Selective binding of polymyxin B to negatively charged lipid monolayers. Biochim. Biophys. Acta 467: 280-289, 1977[Medline].

20.   Tzan, C. J., J. R. Berg, and S. A. Lewis. Effect of protamine sulfate on the permeability properties of the mammalian urinary bladder. J. Membr. Biol. 133: 227-242, 1993[Medline].

21.   Tzan, C. J., J. R. Berg, and S. A. Lewis. Modification of epithelial permeability by cationic polypeptides. Am. J. Physiol. 265 (Cell Physiol. 34): C1637-C1647, 1993[Abstract/Free Full Text].

22.   Tzan, C. J., J. R. Berg, and S. A. Lewis. Mammalian urinary bladder permeability is altered by cationic proteins: modulation by divalent cations. Am. J. Physiol. 267 (Cell Physiol. 36): C1013-C1026, 1994[Abstract/Free Full Text].

23.   Vaara, M. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56: 395-411, 1992[Abstract/Free Full Text].

24.   Vaara, M., and T. Vaara. Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature 33: 526-528, 1983.


Am J Physiol Renal Physiol 275(2):F204-F215
0002-9513/98 $5.00 Copyright © 1998 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
J. R. Lewis and S. A. Lewis
Colistin interactions with the mammalian urothelium
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C913 - C922.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berg, J. R.
Right arrow Articles by Lewis, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, J. R.
Right arrow Articles by Lewis, S. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online